1-17 of 17
Casey O’Connell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Add-on Parsaclisib to Ruxolitinib Therapy in Myelofibrosis Patients With Suboptimal Response to Ruxolitinib: Final Results From a Phase 2 Study

Abdulraheem Yacoub, Uma Borate, Raajit K Rampal, Haris Ali, Eunice Wang, Aaron T. Gerds, Gabriela S. Hobbs, Marina Kremyanskaya, Elliott Winton, Casey O'Connell, Swati Goel, Stephen T Oh, Gary J. Schiller, Albert Assad, Sue Erickson-Viitanen, Feng Zhou, Naval Daver
Journal: Blood
Blood (2022) 140 (Supplement 1): 579–582.
https://doi.org/10.1182/blood-2022-160384
Published: 2022
Journal Articles

Novel Machine Learning Algorithm Predicts Disease Progression in Polycythemia Vera (PV) with Readily-Available Baseline Characteristics

Andrew Srisuwananukorn, Beth Percha, Ghaith Abu-Zeinah, Joseph Scandura, Spencer Krichevsky, Elwood Taylor, III, Richard T. Silver, Santiago Thibaud, Lukas Ronner, Nikolai Podoltsev, Jason Gotlib, Mark L. Heaney, Andrew T. Kuykendall, Casey O'Connell, Jamile M. Shammo, Angela Fleischman, Ruben A. Mesa, Abdulraheem Yacoub, Ronald Hoffman, John Mascarenhas, Douglas Tremblay
Journal: Blood
Blood (2021) 138 (Supplement 1): 2583.
https://doi.org/10.1182/blood-2021-150561
Published: 2021
Journal Articles

Subgroup Analysis from a Phase 2 Study of the Efficacy and Safety of Parsaclisib, a Selective PI3Kδ Inhibitor, in Combination with Ruxolitinib in Patients with Myelofibrosis (MF)

Abdulraheem Yacoub, Uma Borate, Raajit Rampal, Haris Ali, Eunice S. Wang, Aaron T. Gerds, Gabriela Hobbs, Marina Kremyanskaya, Elliott Winton, Casey O'Connell, Swati Goel, Stephen Oh, Gary J. Schiller, Albert Assad, Sue Erickson-Viitanen, Feng Zhou, Naval Daver
Journal: Blood
Blood (2021) 138 (Supplement 1): 3647.
https://doi.org/10.1182/blood-2021-148668
Published: 2021
Journal Articles

Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study

Clinical Trials & Observations
Guillermo Garcia-Manero, Elizabeth A. Griffiths, David P. Steensma, Gail J. Roboz, Richard Wells, James McCloskey, II, Olatoyosi Odenike, Amy E. DeZern, Karen Yee, Lambert Busque, Casey O’Connell, Laura C. Michaelis, Joseph Brandwein, Hagop Kantarjian, Aram Oganesian, Mohammad Azab, Michael R. Savona
Journal: Blood
Blood (2020) 136 (6): 674–683.
https://doi.org/10.1182/blood.2019004143
Published: 2020
Journal Articles

Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis

Clinical Trials & Observations
Lukas Ronner, Nikolai Podoltsev, Jason Gotlib, Mark L. Heaney, Andrew T. Kuykendall, Casey O’Connell, Jamile Shammo, Angela G. Fleischman, Robyn M. Scherber, Ruben Mesa, Abdulraheem Yacoub, Cecelia Perkins, Shelby Meckstroth, Lindsey Behlman, Matthew Chiaramonte, Mahta Salehi, Kimia Ziadkhanpour, Hellen Nguyen, Olivia Siwoski, Annie Kwok Hung, Michelle Janania Martinez, Jenny Nguyen, Sagar Patel, Revathi Kollipara, Ami Dave, Megan Randall, Michael Grant, Mitchell Harrison, Paola Fernandez Soto, Douglas Tremblay, Ronald Hoffman, Erin Moshier, John Mascarenhas
Journal: Blood
Blood (2020) 135 (19): 1696–1703.
https://doi.org/10.1182/blood.2019003347
Published: 2020
Includes: Supplemental data
Journal Articles

The TEMPI syndrome

Clinical Trials & Observations
David B. Sykes, Casey O’Connell, Wilfried Schroyens
Journal: Blood
Blood (2020) 135 (15): 1199–1203.
https://doi.org/10.1182/blood.2019004216
Published: 2020
Includes: Supplemental data
Journal Articles

Comprehensive Molecular Profiling of Idiopathic Erythrocytosis By Genetic Ancestry

Caitlin O'Neill, MD, Zarko Manojlovic, PhD BS, Ah-Reum Jeong, MD, Yili Xu, MS, Yuxin Jin, MS, Sharon Chang, BS, Eric Kwok, BS, Michelle Webb, MS, Casey O'Connell, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 945.
https://doi.org/10.1182/blood-2019-122619
Published: 2019
Journal Articles

A Phase 2 Study of the Safety and Efficacy of INCB050465, a Selective PI3Kδ Inhibitor, in Combination with Ruxolitinib in Patients with Myelofibrosis

Naval G. Daver, MD, Marina Kremyanskaya, MD PhD, Casey O'Connell, MD, Kim-Hien Dao, DO,PhD, Stephen T Oh, MD PhD, Aaron T. Gerds, MDMS, Srdan Verstovsek, MD PhD, Sue Erickson-Viitanen, PhD, Feng Zhou, Albert Assad, MD, Abdulraheem Yacoub, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 353.
https://doi.org/10.1182/blood-2018-99-111338
Published: 2018
Journal Articles

Hepcidin Suppression By Momelotinib Is Associated with Increased Iron Availability and Erythropoiesis in Transfusion-Dependent Myelofibrosis Patients

Stephen T Oh, MD PhD, Moshe Talpaz, MD, Aaron T. Gerds, MDMS, Vikas Gupta, MD FRCP, FRCPath, Srdan Verstovsek, MD PhD, Ruben A. Mesa, MD FACP, Carole Brennan Miller, MD, Candido E. Rivera, MD, Angela Fleischman, MD PhD, Swati Goel, Mark L Heaney, MD PhD, Casey O'Connell, MD, Murat Arcasoy, MD, Yafeng Zhang, PhD MD, Jun Kawashima, MD, Tomas Ganz, MD PhD, Carrie Baker Brachmann
Journal: Blood
Blood (2018) 132 (Supplement 1): 4282.
https://doi.org/10.1182/blood-2018-99-111349
Published: 2018
Journal Articles

How I treat incidental pulmonary embolism

CME
Casey O’Connell
Journal: Blood
Blood (2015) 125 (12): 1877–1882.
https://doi.org/10.1182/blood-2014-08-551879
Published: 2015
Journal Articles

First Clinical Results of a Randomized Phase 2 Dose-Response Study of SGI-110, a Novel Subcutaneous (SC) Hypomethylating Agent (HMA), in 102 Patients with Intermediate (Int) or High Risk (HR) Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Guillermo Garcia-Manero, MD, Ellen K. Ritchie, MD, Katherine Walsh, MD, Michael Savona, MD, Patricia Kropf, MD, Casey O'Connell, MD, Raoul Tibes, MD, Naval G. Daver, MD, Elias Jabbour, MD, Scott Lunin, MD, Todd L. Rosenblat, MD, Karen Yee, MD, Wendy Stock, MD, Elizabeth A. Griffiths, MD, Joseph R Mace, MD, Nikolai A. Podoltsev, MDPhD, Jesus G. Berdeja, MD, Jean-Pierre Issa, MD, Woonbok Chung, PhD, Sue Naim, Pietro Taverna, PhD, Yong Hao, PhD, Mohammad Azab, MD, Hagop M. Kantarjian, MD, Gail J. Roboz, MD
Journal: Blood
Blood (2014) 124 (21): 529.
https://doi.org/10.1182/blood.V124.21.529.529
Published: 2014
Journal Articles

Ethnic and Racial Difference In H.Pylori Infection In Patients With ITP Treated At A MAJOR Tertiary Medical Center In LOS Angeles

Caitlin M O'Neill, BA, Ulysses Gomez, BA, Ilene C Weitz, MD, Casey O'Connell, MD, Howard Liebman, MD
Journal: Blood
Blood (2013) 122 (21): 3548.
https://doi.org/10.1182/blood.V122.21.3548.3548
Published: 2013
Journal Articles

Autoimmune Myelofibrosis (AIMF) – Clinical Features, Course and Outcome

Caroline Irene Piatek, M.D., Maria E. Vergara-Lluri, M.D., Vinod Pullarkat, MD, Imran N. Siddiqi, M.D, Ph.D., Casey O'Connell, MD, Donald I. Feinstein, MD, Russell K. Brynes, MD
Journal: Blood
Blood (2013) 122 (21): 3714.
https://doi.org/10.1182/blood.V122.21.3714.3714
Published: 2013
Journal Articles

Effects Of Dalteparin On The Heparanase/Syndecan-1 Axis In a Randomized Phase 2 Clinical Trial Of Patients With Treatment-Naive Multiple Myeloma

Sikander Ailawadhi, M.D., Howard A Liebman, MD, Susan Groshen, PhD, Denice D. Tsao-Wei, PhD, Leanne Rochanda, MS, Ibrahim Aldoss, MD, Casey O'Connell, MD, Teresa Wang, Christine Duran, Frederick Rickles, MD, FACP
Journal: Blood
Blood (2013) 122 (21): 5350.
https://doi.org/10.1182/blood.V122.21.5350.5350
Published: 2013
Journal Articles

Romiplostim For Thrombocytopenia in Patients with Hepatitis C (HCV)-Associated Liver Disease: Preliminary Report Of An Ongoing Clinical Trial

Howard Liebman, MD, Laurie Hornor, BA, Tse-Ling Fong, MD, Casey O'Connell, MD, Ilene C Weitz, MD
Journal: Blood
Blood (2013) 122 (21): 3555.
https://doi.org/10.1182/blood.V122.21.3555.3555
Published: 2013
Journal Articles

DNA Demethylation Activity Over Time and Safety Of 3 Different Dose-Escalation Regimens Of SGI-110, a Novel Subcutaneous (SQ) Hypomethylating Agent (HMA), In The Treatment Of Relapsed/Refractory Patients With MDS and AML

Gail J. Roboz, MD, Jean-Pierre Issa, MD, David Rizzieri, MD, Wendy Stock, MD, Casey O'Connell, MD, Karen Yee, MD, Raoul Tibes, MD, Elizabeth A. Griffiths, MD, Katherine Walsh, MD, Eric J. Feldman, MD, Ellen Ritchie, MD, Arati V. Rao, MD, Richard A. Larson, MD, Guillermo Garcia-Manero, MD, Farhad Ravandi, MD, Elias Jabbour, MD, Jorge E. Cortes, MD, Aaron Schimmer, PhD, MD, Ruben A. Mesa, MD, William Blum, MD, Woonbok Chung, PhD, Sue Naim, Pietro Taverna, PhD, Yong Hao, PhD, Gavin Choy, PharmD, Mohammad Azab, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2013) 122 (21): 1548.
https://doi.org/10.1182/blood.V122.21.1548.1548
Published: 2013
Journal Articles

First Clinical Results Of a Randomized Phase 2 Study Of SGI-110, a Novel Subcutaneous (SQ) Hypomethylating Agent (HMA), In Adult Patients With Acute Myeloid Leukemia (AML)

Hagop M. Kantarjian, MD, Elias Jabbour, MD, Karen Yee, MD, Patricia Kropf, MD, Casey O'Connell, MD, Wendy Stock, MD, Raoul Tibes, MD, PhD, David Rizzieri, MD, Katherine Walsh, MD, Elizabeth A. Griffiths, MD, Gail J. Roboz, MD, Michael Savona, MD, Thomas Ervin, MD, Nikolai A. Podoltsev, MD, Naveen Pemmaraju, MD, Naval Daver, MD, Guillermo Garcia-Manero, MD, Gautam Borthakur, MD, William G. Wierda, MD, Farhad Ravandi, MD, Jorge E. Cortes, MD, Joseph M. Brandwein, MD, Olatoyosi Odenike, MBBS, Eric J. Feldman, MD, Woonbok Chung, PhD, Sue Naim, Gavin Choy, PharmD, Pietro Taverna, PhD, Yong Hao, PhD, George Dimitrov, MD, Mohammad Azab, MD, Jean-Pierre Issa, MD
Journal: Blood
Blood (2013) 122 (21): 497.
https://doi.org/10.1182/blood.V122.21.497.497
Published: 2013